Kent Charles Roberts II - Oct 3, 2022 Form 4 Insider Report for BIOLARGO, INC. (BLGO)

Role
Director
Signature
/s/ John R. Browning, Attorney-in-fact
Stock symbol
BLGO
Transactions as of
Oct 3, 2022
Transactions value $
$0
Form type
4
Date filed
10/5/2022, 08:31 PM
Previous filing
Jul 5, 2022

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction BLGO Option to Purchase Common Stock Award +55.6K +2.29% 2.48M Oct 3, 2022 Common stock 55.6K $0.27 Direct F1, F2
transaction BLGO Option to Purchase Common Stock Award +23.8K +0.96% 2.5M Oct 3, 2022 Common stock 23.8K $0.27 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This Option was issued to Reporting Person as payment for $15,000 in fees due to Reporting Person by Issuer in exchange for services on its board of directors for the most recently completed quarterly period, pursuant to the Issuer's 2018 Equity Incentive Plan.
F2 The total reflects the October 2, 2022 expiration of options to purchase 47,500 shares of Issuer's common stock.
F3 This Option was granted to Reporting Person to replace an option that had been issued approximately 10 years ago to compensate Reporting Person for services to the Issuer and had recently expired unexercised due to a discrepancy between the original exercise price and current Issuer stock price, pursuant to plan adopted by the Issuer's Compensation Committee.